Lumigan vs Addyi: side-by-side comparison
Lumigan (Eye Care and Ophthalmic Treatments) and Addyi (Women's Sexual Health) belong to different therapeutic classes and are rarely interchangeable. This page compares the medications' purposes, mechanisms and the situations where each is used.
| Property | Lumigan | Addyi |
|---|---|---|
| Active ingredient | Bimatoprost | Flibanserin |
| Manufacturer | AbbVie / Allergan | Sprout Pharmaceuticals |
| Class | Eye Care and Ophthalmic Treatments | Women's Sexual Health |
| Strengths | 0.01%, 0.03% | 100mg |
| Forms | ophthalmic solution | tablet |
What's the same
Lumigan and Addyi are used in very different patients, and the points in common are limited. The main shared element is that both meet regulatory standards for efficacy and safety and benefit from pharmacist oversight.
Key differences
Lumigan belongs to Eye Care and Ophthalmic Treatments while Addyi belongs to Women's Sexual Health. Indications, mechanisms and target populations differ. The comparison is most useful when a clinician has mentioned both medications and the patient wants to understand where each fits.
Mechanism and action
Lumigan: Bimatoprost is a prostamide analogue that increases aqueous humour outflow through both the trabecular meshwork and the uveoscleral pathway, lowering intraocular pressure. Addyi: Sexual desire is modulated by complex central nervous system pathways involving serotonin (generally inhibitory) and dopamine and norepinephrine (generally excitatory).
When Lumigan is preferred
Lumigan is approved in adults for the reduction of elevated intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.
When Addyi is preferred
Addyi is indicated for the treatment of acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women.
Frequently asked questions
Is Lumigan or Addyi better? ▾
Lumigan and Addyi are not interchangeable — they treat different conditions. Asking which is "better" is meaningful only when a clinician has weighed both for the same specific clinical scenario.
Can I switch from Lumigan to Addyi? ▾
Switching between Lumigan and Addyi is rarely an appropriate decision since they belong to different classes and treat different conditions. The real question is usually whether the diagnosis calls for one medication or the other — which the prescriber resolves.
Do Lumigan and Addyi have the same side effects? ▾
No — they belong to different classes and have distinct side-effect profiles. Each medication has its own prescribing information.
More Lumigan comparisons
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.